Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Agreement with Grünenthal for rights to Nexium in Europe and Vimovo worldwide (ex-US)
-
Phase III HARMONIZE Global trial of Lokelma confirms efficacy in maintaining normal potassium levels in Asian patients with hyperkalaemia
-
AstraZeneca strengthens and expands oncology development and commercialisation collaboration with Innate Pharma
-
AstraZeneca to present new data demonstrating breadth of research portfolio in renal disease at ASN Kidney Week 2018
-
SOLO-1 Phase III trial demonstrates Lynparza maintenance therapy cut risk of disease progression or death by 70% in patients with newly-diagnosed, advanced BRCA-mutated ovarian cancer
-
New data on mechanisms of acquired resistance after 1st-line Tagrisso in NSCLC support initiation of ORCHARD trial to explore post-progression treatment options
-
CHMP issues a positive opinion for Bevespi Aerosphere for the treatment of chronic obstructive pulmonary disease
-
US FDA grants Lynparza Orphan Drug Designation for pancreatic cancer
-
AstraZeneca presents advances in improving treatment options for ovarian and lung cancer patients at ESMO 2018 Congress
-
Imfinzi is the first immunotherapy to demonstrate significant overall survival benefit in unresectable, Stage III lung cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
